"Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults Aged 10 to 55 Years"

StatusActive
Effective start/end date10/06/1610/06/21

Funding

  • Sanofi Pasteur, Inc.: $97,325.00

Keywords

  • Biotechnology & Drug Development, Other